Related references
Note: Only part of the references are listed.MYH9-related disease: Five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations
Daniela De Rocco et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2013)
The mechanism of the converter domain rotation in the recovery stroke of myosin motor protein
Andrij Baumketner
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2012)
A Trp33Arg Mutation at Exon 1 of the MYH9 Gene in a Korean Patient with May-Hegglin Anomaly
Moon Ju Jang et al.
YONSEI MEDICAL JOURNAL (2012)
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity
Keri B. Sanborn et al.
BLOOD (2011)
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias
Carlo L. Balduini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Renal manifestations of patients with MYH9-related disorders
Kyoung Hee Han et al.
PEDIATRIC NEPHROLOGY (2011)
Structural and Functional Insights into the Myosin Motor Mechanism
H. Lee Sweeney et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 39 (2010)
Advances in the understanding of MYH9 disorders
Shinji Kunishima et al.
CURRENT OPINION IN HEMATOLOGY (2010)
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype
Alessandro Pecci et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease
Takashi Sekine et al.
KIDNEY INTERNATIONAL (2010)
Heavy chain myosin 9-related disease (MYH9-RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder
Anna Savoia et al.
THROMBOSIS AND HAEMOSTASIS (2010)
MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis
Karina Althaus et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Non-muscle myosin II takes centre stage in cell adhesion and migration
Miguel Vicente-Manzanares et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
MYH9 related disease: A novel missense Ala95Asp mutation of the MYH9 gene
Daniela de Rocco et al.
PLATELETS (2009)
MYH9-Related Platelet Disorders
Karina Althaus et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease
Alessandro Pecci et al.
HUMAN MUTATION (2008)
Head-head and head-tail interaction: A general mechanism for switching off myosin II activity in cells
Hyun Suk Jung et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome)
Alessandro Pecci et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Structures of smooth muscle myosin and heavy meromyosin in the folded, shutdown state
Stan A. Burgess et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Myosin II isoforms in smooth muscle: heterogeneity and function
Thomas J. Eddinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Genotype-phenotype correlation in MYH9-related thrombocytopenia
F Dong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Altered cytoskeleton organization in platelets from patients with MYH9-related disease
I Canobbio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly
JD Franke et al.
BLOOD (2005)
Myosin subfragment 1 structures reveal a partially bound nucleotide and a complex salt bridge that helps couple nucleotide and actin binding
D Risal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Crystal structure of scallop myosin S1 in the pre-power stroke state to 2.6 A resolution:: Flexibility and function in the head
S Gourinath et al.
STRUCTURE (2003)
Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: Association of subcellular localization with MYH9 mutations
S Kunishima et al.
LABORATORY INVESTIGATION (2003)
Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function
AH Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes
KE Heath et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome)
S Kunishima et al.
BLOOD (2001)
X-ray structures of the apo and MgATP-bound states of Dictyostelium discoideum myosin motor domain
CB Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9
AK Lalwani et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Myosins: a diverse superfamily
JR Sellers
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly
MJ Kelley et al.
NATURE GENETICS (2000)
Share Paper
